Discover
IXHL
Incannex Healthcare Inc.
3.10
2 x 3.18
2 x 3.13
bid
ask
-
0.10
3.13%
2 @ 07:20 PM
3.11 +0.01 (0.32%)
| Ytd | -71.14% | |
| 1y | -75.40% |
3.09
day range
3.24
2.56
52 week range
14.37
| Open | 3.17 | Prev Close | 3.20 | Low | 3.09 | High | 3.24 | Mkt Cap | 38.89M |
| Vol | 43.80K | Avg Vol | 94.75K | EPS | -1.66 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 2.21 | Short Ratio | 1.76 | Inst. Own | 4.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 3.32 | 200-d Avg | 4.92 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 5.19M | ||
| Research and Development Expense | 1.49M | ||
| Selling, General and Administrative Expense | 3.70M | ||
| Operating Income | -5.19M | ||
| Net Income | -2.49M | ||
| Net Income Common Stock | -2.49M | ||
| Net Income Common Stock (USD) | -2.49M | ||
| Consolidated Income | -2.49M | ||
| Earnings per Basic Share | -0.15 | ||
| Earnings per Basic Share (USD) | -0.15 | ||
| Earnings per Diluted Share | -0.15 | ||
| Earning Before Interest & Taxes (EBIT) | -2.49M | ||
| Earning Before Interest & Taxes (USD) | -2.49M | ||
| Weighted Average Shares | 12.28M | ||
| Weighted Average Shares Diluted | 12.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 67.71M | ||
| Cash and Equivalents (USD) | 67.71M | ||
| Investments | 51.00K | ||
| Investments Non-Current | 51.00K | ||
| Current Assets | 72.83M | ||
| Property, Plant & Equipment Net | 101.00K | ||
| Total Assets | 72.98M | ||
| Debt Current | 62.00K | ||
| Total Debt | 96.00K | ||
| Current Liabilities | 1.49M | ||
| Debt Non-Current | 34.00K | ||
| Total Liabilities | 5.61M | ||
| Accumulated Retained Earnings (Deficit) | -176.86M | ||
| Accumulated Other Comprehensive Income | -3.58M | ||
| Shareholders Equity | 67.37M | ||
| Shareholders Equity (USD) | 67.37M | ||
| Assets Non-Current | 152.00K | ||
| Total Debt (USD) | 96.00K | ||
| Liabilities Non-Current | 4.11M | ||
| Trade and Non-Trade Payables | 1.16M | ||
| Tax Assets | 4.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 50.00K | ||
| Net Cash Flow from Financing | -6.91M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.57M | ||
| Capital Expenditure | 1000 | ||
| Net Cash Flow - Business Acquisitions and Disposals | -31.00K | ||
| Issuance (Purchase) of Equity Shares | -7.03M | ||
| Net Cash Flow from Investing | -30.00K | ||
| Net Cash Flow from Operations | 3.37M | ||
| Effect of Exchange Rate Changes on Cash | -3.17M | ||
| Share Based Compensation | 1.19M | ||